Parkinson's disease : molecular and therapeutic insights from model systems /

Parkinson's disease : molecular and therapeutic insights from model systems /

42

Bibliographic Details
Main Authors:	Nass, Richard, Przedborski, Serge
Format:
Language:	eng
Published:	New York : Academic Press, 2008
Subjects:	Parkinsons disease Biological models

Similar Items

Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease
by: Meijun Pang, et al.
Published: (2022-11-01)

Genetic Risk Profiling in Parkinson’s Disease and Utilizing Genetics to Gain Insight into Disease-Related Biological Pathways
by: Ashley Hall, et al.
Published: (2020-10-01)

Mechanistic models of α-synuclein homeostasis for Parkinson's disease: A blueprint for therapeutic intervention
by: Elena Righetti, et al.
Published: (2022-12-01)

Therapeutics of parkinson's disease and other movement disorders /
by: Hallett, Mark, et al.
Published: (2008)

Norepinephrine: the next therapeutics frontier for Parkinson's disease
by: LeWitt Peter A
Published: (2012-01-01)

Gene-Based Therapeutics for Parkinson’s Disease
by: Karim E. Shalaby, et al.
Published: (2022-07-01)

Parkinson's disease : non-motor and non-dopaminergic features /
by: Olanow, C. W. (Charles Warren), 1941-, et al.
Published: (2011)

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
by: Yue Huang, et al.
Published: (2023-05-01)

Psychotic symptoms and Parkinson’s Disease: Clinical and Therapeutic Aspects
by: D. Nzamba Nzamba, et al.
Published: (2022-06-01)

Parkinsons disease /
by: 370330 Goldstein, Nathan
Published: (2008)

Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
by: Victor A. D. Holanda, et al.
Published: (2021-08-01)

Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
by: Wendy Balestri, et al.
Published: (2024-01-01)

Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic
by: Feldman M, et al.
Published: (2022-12-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Restorative therapies in Parkinsons disease /
by: Brundin, Patrik, et al.
Published: (2006)

Lipopolyplex for therapeutic gene delivery and its application for the treatment of Parkinson’s disease
by: Wei eChen, et al.
Published: (2016-04-01)

Targeting the pathogenesis and boosting the therapeutic efficacy of Parkinson's disease by advanced nanoparticles
by: Hanghang Liu, et al.
Published: (2023-06-01)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
by: Yu Zhang, et al.
Published: (2023-02-01)

Historical Perspective: Models of Parkinson’s Disease
by: Shyh Jenn Chia, et al.
Published: (2020-04-01)

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
by: Yashumati Ratan, et al.
Published: (2024-01-01)

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
by: Katherine Muksuris, et al.
Published: (2023-08-01)

Tyrosinase-Expressing Neuronal Cell Line as in Vitro Model of Parkinson’s Disease
by: Takafumi Hasegawa
Published: (2010-03-01)

Association analysis of PSAP variants in Parkinson's disease patients
by: Chao, Yin Xia, et al.
Published: (2021)

Search for Molecular Biomarkers of Parkinson’s Disease. New Tissues and Methods
by: Peter Racay
Published: (2023-04-01)

Parkinson's disease : diagnosis and clinical management /
by: Factor, Stewart A., 1956-, et al.
Published: (2008)

Evaluation of novel Parkinson's disease candidate genes in the Chinese population
by: Chew, Elaine Guo Yan, et al.
Published: (2020)

Parkinson's disease : clinician's desk reference /
by: Grosset, Donald
Published: (2009)

The overview of the therapeutic strategy for motor complications of Parkinson's disease
by: Ying WAN, et al.
Published: (2013-08-01)

Parkinson’s disease and depression
by: A. Maamri, et al.
Published: (2021-04-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
by: Srinivasa Reddy Bonam, et al.
Published: (2021-12-01)

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
by: Marta Pajares, et al.
Published: (2020-07-01)

Therapeutic potential of extracellular vesicles in Parkinson’s disease
by: Michelli Ramires Teixeira, et al.
Published: (2023-06-01)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2023-06-01)

Neural vulnerability in models of Parkinson's disease
by: Mo, M, et al.
Published: (2007)

Biological Implications of Differential Expression of Mitochondrial-Shaping Proteins in Parkinson’s Disease
by: Sara Rocha, et al.
Published: (2017-12-01)

ITPKB and ZNF184 are associated with Parkinson’s disease risk in East Asians
by: Chew, Elaine Guo Yan, et al.
Published: (2020)

Parkinsons disease management pack participant's manual /
by: 385086 Swinburn, Kate, et al.
Published: (1996)

Parkinsons disease and the family : a new guide /
by: 222892 Sharma, Nutan, et al.
Published: (2005)

Animal Models of Autosomal Recessive Parkinsonism
by: Guendalina Bastioli, et al.
Published: (2021-07-01)

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS FOR PARKINSONISM AND PARKINSON'S DISEASE IN KRASNODAR REGION
by: D. K. Sichinava, et al.
Published: (2019-02-01)